BioCanRx has set the next intake date for funding applications in its rolling, open call process. BioCanRx builds on past and ongoing investments in the area of cancer biotherapeutics that have a clear path to, or are ready for, clinical trials. They are strengthening Canada’s ability to translate the unfolding promise of immune-based cancer therapies into benefits for patients.
BioCanRx is ready to hear about your project at anytime, but have set intake dates to work with the meeting dates of our Research Management Committee (RMC).
Important Date:
The next intake deadline is November 9, 2016, by 11:59 p.m. EDT